Hook / Thesis
If you want exposure to the cannabis sector but prefer a cash-yielding, lower-volatility vehicle, NewLake Capital Partners (NLCP) is worth a tactical haircut versus owning the sector via MSOS. NLCP is a cannabis-focused REIT that is paying a quarterly cash dividend of $0.43 ($1.72 annualized) and reported full-year AFFO of $2.09 per share — figures that translate into a double-digit dividend yield and a reasonable AFFO coverage ratio today.
The trade here is directional and time-boxed. I favor a long position in NLCP at the market ($13.94) for a mid-term horizon of 45 trading days. The thesis: the stock is oversold technically, trades on the OTC market where income securities often discount risk, and carries clear yield support that should attract income-seeking flows if the sector stabilizes. Versus MSOS (a diversified cannabis-equity ETF), NLCP offers income and capital protection via long-term leases and strong liquidity on the balance sheet — at the cost of less upside capture if the equity rally becomes broad and fast.
What NewLake Does and Why It Matters
NewLake Capital Partners is a REIT that provides real estate capital to state-licensed cannabis operators. The company owns 34 properties across cultivation and retail footprints — specifically 15 cultivation facilities and 19 dispensaries. That mix matters: cultivation assets tend to have higher tenant specialization (and therefore credit risk), while dispensaries offer cash-flowing retail exposure tied to consumer demand.
From a fundamentals standpoint the business is showing durability. NewLake reported Q4 revenue of $12.3 million and full-year revenue of $51.1 million, with AFFO of $0.51 in Q4 and $2.09 for the full year. Liquidity sits at $106.3 million and the company reports minimal debt — a combination that should allow the firm to manage tenant transitions without forcing asset sales. The company has also been consistent on distributions, declaring a quarterly cash dividend of $0.43 per share for multiple quarters in 2025 and into 2026.
How the Market Should Think About NLCP vs. MSOS
- Income-first vs. beta-first: NLCP is an income vehicle — annualized dividends of $1.72 represent a yield near 12.3% at a $13.94 share price. That yield is supported by AFFO of $2.09 per share, implying an AFFO payout ratio of about 82% (1.72 / 2.09). MSOS offers broad equity exposure; it captures upside if the entire cannabis complex re-rates but with more day-to-day volatility and no direct cash distribution comparable to a REIT dividend.
- Balance sheet and tenant risk: NewLake’s $106.3 million of liquidity and minimal leverage reduce the chance it will need to cut the dividend immediately in the event of isolated tenant defaults. However, tenant dislocations have happened: management references issues with AYR Wellness and Revolutionary Clinics. Those events raise the credit-watch on revenues and need to be watched closely.
- Listing and liquidity: NLCP trades on OTC Link, a structural disadvantage versus exchange-listed ETFs like MSOS. That leads to wider bid/ask spreads and episodic volume, but also a potential valuation discount for patient buyers.
Hard Numbers to Anchor the Thesis
| Metric | Figure |
|---|---|
| Q4 2025 Revenue | $12.3M |
| FY 2025 Revenue | $51.1M |
| AFFO Q4 / FY | $0.51 / $2.09 per share |
| Quarterly Dividend | $0.43 per share (annualized $1.72) |
| Liquidity | $106.3M |
| Portfolio | 34 properties (15 cultivation, 19 dispensaries) |
Technicals and Market Sentiment
The technical backdrop is mixed-but-favorable for a mean-reversion trade. Key moving averages sit above the current price (10-day SMA ~$14.35, 20-day SMA ~$14.85, 50-day SMA ~$15.27), and the nine-day EMA is ~$14.25. Momentum indicators show the stock is oversold: RSI sits at ~27.8. MACD is negative with a bearish histogram, suggesting momentum remains tilted downward. On the sentiment side, short-volume readings have been significant in recent sessions (for example on 04/09 short volume represented a majority of the day’s trades), which creates both downside pressure and the potential for a short-covering bounce if any positive catalyst arrives.
Valuation Framing
NLCP trades as an income-heavy, small-cap REIT with an elevated yield (roughly 12.3% on the current price). Using AFFO as a valuation anchor, the stock’s AFFO yield is roughly 15% (2.09 / 13.94), which is attractive on the surface for income investors. Small-cap OTC REITs frequently trade at yield premiums to larger publicly listed peers because of lower liquidity and higher perceived operational/tenant risk. If the company continues to collect rents and maintain liquidity, those yield spreads can compress and provide capital appreciation in addition to income.
Catalysts (2-5)
- Resolution or re-leasing of properties affected by AYR Wellness and Revolutionary Clinics - concrete improvements in occupancy will materially reduce downside risk.
- Continued dividend declarations at $0.43 per quarter or higher - signals management confidence and supports yield-focused demand.
- Positive regulatory headlines (state-level market expansions or federal regulatory progress) that spur broad cannabis equity inflows into MSOS and related names - this often lifts real assets indirectly.
- Any move toward an exchange listing or improved market-making for NLCP would likely narrow yield spreads and support repricing.
Trade Plan (Actionable)
Position: Long NLCP
Entry: Buy at $13.94
Stop-loss: $12.00 (if price breaks $12.00, downside momentum suggests re-test of lower levels)
Target: $17.50
Horizon: mid term (45 trading days) - I expect this window to be sufficient to see mean reversion with potential catalyst-driven rerating or a short-covering move. If the stock is range-bound at the target and fundamentals remain intact, consider rolling to a longer position with tightened risk management.
Rationale for levels: Entry is at the current market price to capture the dividend yield and upside if the REIT rerates. The stop at $12.00 protects capital if tenant credit issues deepen or liquidity proves inadequate. The $17.50 target implies roughly 25% upside from entry and reflects a partial compression of yield toward peers and the potential impact of a short-covering rally.
Risk Framework and Counterarguments
- Tenant credit risk: Cannabis operators remain financially stressed in several states. Additional tenant defaults or protracted vacancies would press AFFO and could force a dividend cut.
- Liquidity and listing risk: Trading on OTC Link means lower liquidity and wider spreads; in stress scenarios, price moves can be exaggerated and exits more difficult.
- Regulatory risk: Federal or state-level regulatory shocks and taxation changes could depress retail cannabis sales and therefore tenant ability to pay rent.
- Sector correlation and ETF outperformance: If the market rotates into growthier cannabis equities (MSOS) on the back of legalization optimism, NLCP may underperform because it offers less upside leverage to operator equity gains.
- Technical risk: The MACD remains negative and moving averages are above price; if momentum accelerates lower, the stop may be hit quickly.
Counterargument to my thesis
One could reasonably argue that owning MSOS is the superior tactical play right now. If broad legalization momentum or capital flows into cannabis equities accelerate, MSOS will capture a multi-bagger style re-rating on the upside while NLCP will merely offer limited capital appreciation plus income. For a pure speculative trader seeking asymmetric upside, the ETF is the better vehicle because it captures operator-level operational improvements and M&A upside that a REIT will not.
Conclusion and What Would Change My Mind
My stance: Initiate a mid-term long position in NLCP at $13.94 for income and mean-reversion upside. The trade is best suited for investors who value cash yield and a balance-sheet buffer over raw upside. The dividend and AFFO coverage provide a rational floor, and recent oversold technicals plus substantial short interest create an asymmetric risk-reward for a 45-trading-day trade.
I would change my view if any of the following occur: (1) the company materially cuts the quarterly dividend (below $0.30 per share) or signals a meaningful deterioration in AFFO guidance; (2) liquidity falls sharply (for example, below $50M) or leverage meaningfully increases; (3) multiple large tenants default or file for bankruptcy, threatening occupancy rates across the portfolio; or (4) the company announces an exchange uplisting and a credible path to improved liquidity, which would likely mean a different valuation approach and could shift the trade toward a longer-term hold rather than a tactical swing.
Bottom line: NLCP is an income-first tactical pick against MSOS’s beta exposure. Buy at $13.94, stop $12.00, target $17.50, and keep the horizon to mid term (45 trading days) unless positive fundamental changes warrant a longer hold.